Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 118Lung Neoplasms 51Triple Negative Breast Neoplasms 35Breast Neoplasms 33Small Cell Lung Carcinoma 27Squamous Cell Carcinoma of Head and Neck 25Ovarian Neoplasms 24Fallopian Tube Neoplasms 20Neoplasm Metastasis 19Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 15Endometrial Neoplasms 15Head and Neck Neoplasms 14Colorectal Neoplasms 10Carcinoma 10Prostatic Neoplasms 9Oropharyngeal Neoplasms 9Carcinoma, Transitional Cell 9Urinary Bladder Neoplasms 7Esophageal Neoplasms 7Carcinoma, Squamous Cell 7Pancreatic Neoplasms 6Lung Diseases 6Laryngeal Neoplasms 6Carcinoma, Ovarian Epithelial 6Uterine Cervical Neoplasms 5Respiratory Tract Neoplasms 5Mouth Neoplasms 5Mesothelioma 5Carcinoma, Bronchogenic 5

Interventions

Cyclophosphamide 25fludarabine 19Dexamethasone 17pembrolizumab 13Rituximab 12venetoclax 9Lenalidomide 9Gemcitabine 9Etoposide 9pomalidomide 8Vincristine 7glofitamab 6fludarabine phosphate 6carfilzomib 6Temozolomide 6obinutuzumab 5daratumumab 5Prednisone 5Nivolumab 5Doxorubicin 5Cisplatin 5Calcium Dobesilate 5Bortezomib 5zanubrutinib 4selinexor 4Immunotherapy, Adoptive 4Cytarabine 4Carboplatin 4Azacitidine 4ruxolitinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recurrence × Carboplatin × 90 days × Clear all
NCT05533775 2026-05-04

iMATRIX GLO

Hoffmann-La Roche

Phase 1/2 Recruiting
65 enrolled

Recurrence

NCT05815160 2026-05-04

Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy

Debiopharm International SA

Phase 1 Terminated
34 enrolled
Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT00864318 2026-04-14

TICE

Institut Claudius Regaud

Phase 2 Completed
101 enrolled

Neoplasms, Germ Cell and Embryonal, Recurrence

NCT07423078 2026-04-13

WOLF

University of Pittsburgh

Phase 2 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡